Vertex Pharmaceuticals Incorporated vs Weibo Corp — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.47 (market cap $121.95B), while Weibo Corp trades at $8 (market cap $1.95B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 62.5× Weibo Corp's market cap, and Weibo Corp pays a 7.63% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| VRTX | WB | |
|---|---|---|
Market Cap | $121.95B | $1.95B |
Sector | Health | Media |
52-Week High | $529.59 | $12.83 |
52-Week Low | $366.54 | $7.20 |
Enterprise Value | $116.69B | $1.22B |
Dividend Yield | — | 7.63% |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →